Back to UBS Group AG UBS Group AG

KPTIKPTI
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in KARYOPHARM THERAPEUTICS INC

UBS Group AG holds 194,017 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $1.1M as of 2026-Q1. The position was increased (+119.3% shares). KPTI represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.1M

Current Shares

194,017

Total Value Change

+$958,567

Total Shares Change

+53,339

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
194,017
+119.3%
$1.1M0.0%$9.13
41
2025-Q4
Increased
88,455
+48.2%
$651,0290.0%$7.31
34
2025-Q3
Decreased
59,685
-63.1%
$390,3400.0%$6.35
0
2025-Q2
Increased
161,900
+73.0%
$697,7890.0%$4.39
37
2025-Q1
Decreased
93,612
-35.8%
$350,1090.0%$4.16
0
2024-Q4
Increased
145,791
+8.4%
$98,5550.0%$10.50
16
2024-Q3
Decreased
134,478
-4.4%
$111,6170.0%$10.86
0
2024-Q2
Decreased
140,678
-44.8%
$122,1080.0%$13.02
0

Other major holders of KPTI: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used